Anzeige
Mehr »
Login
Donnerstag, 24.04.2025 Börsentäglich über 12.000 News von 692 internationalen Medien
Jetzt knallt's an der Börse! Diese Aktie hat das Zeug zum Überflieger!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PA3U | ISIN: CA58410Q2036 | Ticker-Symbol: P731
Frankfurt
24.04.25
08:02 Uhr
1,590 Euro
+0,020
+1,27 %
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
MEDEXUS PHARMACEUTICALS INC Chart 1 Jahr
5-Tage-Chart
MEDEXUS PHARMACEUTICALS INC 5-Tage-Chart

Aktuelle News zur MEDEXUS PHARMACEUTICALS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
17.04.Medexus Pharmaceuticals Inc: Medexus completes listing agreement for Trecondyv1
17.04.Stocks in Play: Medexus Pharmaceuticals-
MEDEXUS PHARMACEUTICALS Aktie jetzt für 0€ handeln
17.04.Medexus Pharmaceuticals Inc.: Medexus Successfully Completes Agreement for Public Reimbursement of Trecondyv (treosulfan for injection) in Quebec, Canada262Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - April 17, 2025) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) recently completed a listing agreement with the provincial government of...
► Artikel lesen
08.04.Medexus is a "Strong Buy", Raymond James says1
07.04.Medexus Pharmaceuticals Inc: Medexus talks up market response to Grafapex1
07.04.Stocks in Play: Medexus Pharmaceuticals-
07.04.Medexus Pharmaceuticals Inc.: Medexus Provides Update on Progress of Commercialization of GRAFAPEX (treosulfan) for Injection231Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - April 7, 2025) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) is pleased to provide a business update on the progress of the commercial...
► Artikel lesen
14.03.Stocks in Play: Medexus Pharmaceuticals-
14.03.Medexus Pharmaceuticals Inc: Medexus completes cancellation of Gleolan U.S. licence2
14.03.Medexus Pharmaceuticals Inc.: Medexus Completes Agreement to Return US Commercialization Rights for Gleolan to NX Development Corp.265Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - March 14, 2025) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) recently completed an agreement with NX Development Corp., the licensor...
► Artikel lesen
24.02.Medexus Pharmaceuticals Inc: Medexus's Grafapex for injection available in U.S.1
24.02.Medexus Pharmaceuticals Inc.: Medexus Announces Commercial Availability of GRAFAPEX (treosulfan) for Injection438Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - February 24, 2025) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) is pleased to announce that GRAFAPEX (treosulfan) for Injection is now...
► Artikel lesen
07.02.Stifel cuts Medexus Pharma stock rating to Hold, target to C$3.453
06.02.Medexus Pharmaceuticals Inc: Medexus Pharmaceuticals to resume at 7:36 a.m. PT2
06.02.Medexus Pharmaceuticals Inc: Medexus Pharmaceuticals halted at 7:31 a.m. PT3
06.02.Medexus targets $100M annual revenue for GRAFAPEX within 5 years post-launch3
05.02.Medexus Pharmaceuticals reports Q3 results3
05.02.Medexus Pharmaceuticals Inc.: Medexus Announces Strong Fiscal Q3 2025 Results, Well-Positioned to Launch GRAFAPEX (treosulfan) for Injection in the United States405Fiscal Q3 2025 revenue of $30.0 million, net income of $0.7 million, operating income of $3.8 million, and Adjusted EBITDA* of $5.8 millionManagement to host conference call at 8:00 AM Eastern time...
► Artikel lesen
04.02.Stocks in Play: Medexus Pharmaceuticals2
04.02.Medexus Pharmaceuticals Inc.: Medexus and Ontario's Provincial Health Services Successfully Complete Agreements for Public Reimbursement of Trecondyv (treosulfan for injection) in Ontario, Canada166Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - February 4, 2025) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) recently completed listing agreements with Ontario's Ministry of Health...
► Artikel lesen
Seite:  Weiter >>
56 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1